Stock GLSI GREENWICH LIFESCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Greenwich LifeSciences, Inc.

Equities

GLSI

US3968791083

Market Closed - Nasdaq
Other stock markets
 03:59:20 2024-06-04 pm EDT 		5-day change 1st Jan Change
14.15 USD +1.14% Intraday chart for Greenwich LifeSciences, Inc. +5.60% +34.51%
May. 20 Greenwich LifeSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 15 Greenwich LifeSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Greenwich LifeSciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

78efd95a40dc7bfc.j0_EvXMmJL21p4UZOB7iArFq4q1H7KBGURz7xES6HjE.xyqGzzxLdOLT87RycEnRTdwijsh2tf8EO1W8mzzwLHLODIrOA1MS-u-XyA~18356a9ad2eba8d8de767a44254e175c

Analyst Recommendations on Greenwich LifeSciences, Inc.

HC Wainwright Adjusts Greenwich LifeSciences Price Target to $36 From $38, Maintains Buy Rating MT
HC Wainwright Cuts Greenwich LifeSciences' Price Target to $38 From $78, Keeps Buy Rating MT
GREENWICH LIFESCIENCES : HC Wainwright Starts Greenwich LifeSciences at Buy with $78 Price Target MT
GREENWICH LIFESCIENCES : Aegis Capital Initiates Coverage on Greenwich LifeSciences at Buy Rating, Sets Price Target at $75 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
14.04 USD
Average target price
36 USD
Spread / Average Target
+156.41%
High Price Target
36 USD
Spread / Highest target
+156.41%
Low Price Target
36 USD
Spread / Lowest Target
+156.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Greenwich LifeSciences, Inc.

HC Wainwright
Aegis Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GLSI Stock
  4. Consensus Greenwich LifeSciences, Inc.